MBBS (Hons), AMP (Harvard), FRANZCOG, CREI
As of 12 July 2019, Dr Robert Woolcott has ceased private practice in order to focus exclusively on Genea.
Robert is and will continue as a Company Director of Genea Limited. He remains Managing and Medical Director of Genea Newcastle, Chief Medical Officer of Genea Biomedx, Chairman of the Medical Practice Committee and an Approved Pathology Provider for the Genea group. At Board level he is involved in the development of company strategy and the maintenance of governance and risk management frameworks. From a functional perspective he will assist doctors and staff continue to refine and optimise patient care and outcomes.